Correction:: Prorenin receptor acts as a potential molecular target for pancreatic ductal adenocarcinoma diagnosis (Oncotarget (2016) 7 (55437-55448) DOI: 10.18632/oncotarget.10583)

Arivajiagane Arundhathi, Wen Han Chuang, Jen Kun Chen, Shin E. Wang, Yi Ming Shyr, Jiun Yu Chen, Wei Neng Liao, Hsin Wei Chen, Yi Min Teng, Chiao Chih Pai, Chih-Hong Wang

Research output: Contribution to journalComment/debate

Abstract

This article has been corrected: Due to an error in proofreading, the total ERK, AKT, and S6K in Figure 4A are incorrect. The proper Figure 4A is shown below. In addition, updates have been made to the 3rd affiliation and a 4th affiliation has been added. Both are shown below. The authors declare that these corrections do not change the results or conclusions of this paper. 3 Department of General Surgery, Taipei Veterans General Hospital, and National Yang Ming University, Taipei, Taiwan 4 Institute of Molecular Medicine and Bioengineering, National Chiao Tung University, Hsinchu, Taiwan. (Figure Presented).

Original languageEnglish
Number of pages1
JournalOncotarget
Volume10
Issue number4
StatePublished - 1 Jan 2019

Fingerprint Dive into the research topics of 'Correction:: Prorenin receptor acts as a potential molecular target for pancreatic ductal adenocarcinoma diagnosis (Oncotarget (2016) 7 (55437-55448) DOI: 10.18632/oncotarget.10583)'. Together they form a unique fingerprint.

Cite this